18 results
-
List item
National expert: Emilio Perucca, Italian Medicines Agency (updated)
- Declaration of interests - 85.84 KB | PDF
- Curriculum Vitae - 116.29 KB | PDF
CRISTALLO, L., DE PASCALE, V., CREMA, A., CRAVERI, F., PERUCCA … BAMONTE, F., CRAVERI, F., CREMA, A., PERUCCA, E. and TEGGIA … POLONI, M., FRIGO, G.M. and CREMA, A. Pharmacokinetics of phenytoin … -
List item
National expert: Antonio Clavenna, European Medicines Agency (updated)
- Declaration of interests - 80.51 KB | PDF
- Curriculum Vitae - 29.74 KB | PDF
Ospedaliera "Ospedale Maggiore" of Crema, Italy. 2.11 Committee … -
List item
National expert: Victor Mangas Sanjuan, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 79.81 KB | PDF
- Curriculum Vitae - 34.19 KB | PDF
Belles-Medall MD, Garcia-Cremades M, Ferrando-Piqueres R, Mangas-Sanjuan … -
List item
National expert: Marta Morado, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 80.28 KB | PDF
- Curriculum Vitae - 24.32 KB | PDF
Rosado S, Morado M, Vallejo-Cremades MT, Martinez A, Vargas-Nunez … -
List item
Human medicine European public assessment report (EPAR): Lutetium (177Lu) chloride Billev (previously Illuzyce)
lutetium (177Lu) chloride, Radionuclide Imaging
Date of authorisation: 15/09/2022, Revision: 1, Authorised, Last updated: 08/12/2022 -
List item
Human medicine European public assessment report (EPAR): Elebrato Ellipta (updated)
fluticasone furoate, umeclidinium bromide, vilanterol trifenatate, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 15/11/2017, Revision: 11, Authorised, Last updated: 22/03/2023 -
List item
Human medicine European public assessment report (EPAR): Trelegy Ellipta (updated)
fluticasone furoate, umeclidinium bromide, vilanterol trifenatate, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 15/11/2017, Revision: 10, Authorised, Last updated: 22/03/2023 -
List item
Human medicine European public assessment report (EPAR): Relvar Ellipta
fluticasone furoate, vilanterol, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 13/11/2013, Revision: 24, Authorised, Last updated: 02/02/2023 -
List item
Human medicine European public assessment report (EPAR): Ketoconazole HRA
Ketoconazole, Cushing Syndrome
Date of authorisation: 18/11/2014,
, 
, 
, Revision: 10, Authorised, Last updated: 07/06/2021
-
List item
Referral: Nimesulide
nimesulide, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/12/2003, EC decision date: 26/04/2004, Last updated: 13/05/2004 -
List item
Referral: EMLA cream and associated names
lidocaine, prilocaine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/09/2014, EC decision date: 28/11/2014, Last updated: 15/01/2015 -
List item
Referral: Piroxicam
piroxicam, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/06/2007, EC decision date: 07/09/2007, Last updated: 31/01/2008 -
List item
Orphan designation: Liarozole for: Treatment of congenital ichthyoses
Date of designation: 10/06/2003, Withdrawn, Last updated: 10/08/2016Pathologiques 63 Allée de la Cremaillère F-59650 Villeneuve d'Ascq … -
List item
National expert: Wouter de Herder, European Medicines Agency (updated)
- Declaration of interests - 81.3 KB | PDF
- Curriculum Vitae - 111.56 KB | PDF
-
List item
Transparency: exceptional measures for COVID-19 medicines
Last updated: 11/03/2022 -
List item
Open letters
Last updated: 07/12/2021 -
List item
Guidance documents
Last updated: 19/07/2022 -
List item
Public data from Article 57 database
Last updated: 17/10/2022